Luxembourg vs Sur: Previously treated cases tested for RR-/MDR-TB
Luxembourg
100.0%
in 2024
Sur
62.0%
in 2024
Luxembourg rank
1st
Sur rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Luxembourg
- Sur
How they compare
Luxembourg currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Luxembourg's figure about 1.6 times Sur's.
The two have swapped places 2 times across 7 shared years of data; in 2011 it was Luxembourg ahead.
Luxembourg ranks 1st and Sur ranks 1st of 180 countries.
Luxembourg has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Luxembourg | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 0.0% | 100.0% | Luxembourg |
| 2020s | 95.0% | 78.4% | 16.6% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Luxembourg or Sur?
- Luxembourg, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Luxembourg and Sur?
- 38.0%, with Luxembourg ahead.
- How many years of comparable data are there for Luxembourg and Sur?
- 7 years are reported by both, from 2011 to 2024.
- How do Luxembourg and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Luxembourg ranks 1st and Sur ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.